About National Institute of Neurosciences and Hospital
National Institute of Neurosciences & Hospital is a state run tertiary care institute in Bangladesh focused on neurological disorders. It is located at Agargaon in Dhaka. Bangladeshi neurologist Prof Quazi Deen Mohammad is the founding director of this institute.
Clinical Trials at National Institute of Neurosciences and Hospital
During the past decade, National Institute of Neurosciences and Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "National Institute of Neurosciences and Hospital"
#1 collaborator was "International Centre for Diarrhoeal Disease Research, Bangladesh" with 1 trials as a collaborator, "National Institute of Neurosciences and Hospital, Dhaka" with 1 trials as a collaborator and "ResearchPoint Global" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at National Institute of Neurosciences and Hospital
According to Clinical.Site data, the most researched conditions in "National Institute of Neurosciences and Hospital" are
"Environmental Exposure" (1 trials), "Guillain-Barré Syndrome" (1 trials), "Hyperglycemia" (1 trials), "Pregnancy; Spina Bifida, Fetal" (1 trials) and "Stroke, Acute" (1 trials). Many other conditions were trialed in "National Institute of Neurosciences and Hospital" in a lesser frequency.
Clinical Trials Intervention Types at National Institute of Neurosciences and Hospital
Most popular intervention types in "National Institute of Neurosciences and Hospital" are "Drug" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "ANX005" (1 trials), "Analog Insulin" (1 trials), "Folic Acid Tablet" (1 trials), "Human insulin" (1 trials) and "Intravenous immunoglobulin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at National Institute of Neurosciences and Hospital
The vast majority of trials in "National Institute of Neurosciences and Hospital" are
2 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at National Institute of Neurosciences and Hospital
Currently, there are NaN active trials in "National Institute of Neurosciences and Hospital".
1 are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in National Institute of Neurosciences and Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in National Institute of Neurosciences and Hospital, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".